panitumumab,bevacizumab
takeda,roche,amgen
[' bev ', 'cairo-5', 'crc,(-ccrcc),(-tbcrc049),(-mccrcc),(-mbcrc)', 'crcsm']
#esmo22 #crcsm cairo-5: for initially unresectable crc liver mets in 230 left ptl ras-wt pts no diff in pfs between chemo+ bev or pan no diff in r0 resection higher orr with pan but more tox improved outcomes with local treatment 
Optimist. GI medical oncologist. Coffee, Irn-Bru & dog enthusiast @foxtrotstudy @focus4trial @ArielTrial #pelotonuk ??????????? ????